Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Completed 2Active not recruiting 1

Sponsor Class

OTHER 1NETWORK 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Pancreatic Neoplasms 6Rectal Neoplasms 5Colonic Neoplasms 3Stomach Neoplasms 2Pancreatic Adenocarcinoma 2Gallbladder Neoplasms 2Colorectal Neoplasms 2Bile Duct Neoplasms 2Urinary Bladder Neoplasms 1Urethral Neoplasms 1Ureteral Neoplasms 1Testicular Neoplasms 1Stage II Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7 1Stage I Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7 1Squamous Cell Carcinoma of Head and Neck 1Pancreatic Intraductal Neoplasms 1Oropharyngeal Neoplasms 1Klatskin Tumor 1Gastrointestinal Neoplasms 1Esophageal Neoplasms 1Cholangiocarcinoma 1Carcinoma, Renal Cell 1Carcinoma, Hepatocellular 1Borderline Resectable Pancreatic Adenocarcinoma 1Anus Neoplasms 1

Interventions

Gemcitabine 7130-nm albumin-bound paclitaxel 5Fluorouracil 3Albumin-Bound Paclitaxel 3dehydroftorafur 2Taxes 2Oxaliplatin 2tocilizumab 1selicrelumab 1niraparib 1cobimetinib 1atezolizumab 1Tiragolumab 1Resistance Training 1Radiotherapy, Intensity-Modulated 1Radiotherapy, Image-Guided 1Radiotherapy, Conformal 1Pancreatectomy 1PEGPH20 1Nivolumab 1Leucovorin 1Irinotecan 1Ipilimumab 1Interleukin 1 Receptor Antagonist Protein 1Erlotinib Hydrochloride 1Electronic Health Records 1Cisplatin 1Bevacizumab 14-fluorobenzoyl-TN-14003 13-aminopyridine-2-carboxaldehyde thiosemicarbazone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Pancreatic Adenocarcinoma × dehydroftorafur × Clear all
NCT02427841 2023-09-06

Nab-paclitaxel and Gemcitabine Hydrochloride Followed by Radiation Therapy Before Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery

OHSU Knight Cancer Institute

Phase 2 Completed
20 enrolled 17 charts
Gastrointestinal

Pancreatic Adenocarcinoma

NCT02562716 2022-10-19

S1505: Combination Chemotherapy or Gemcitabine Hydrochloride and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Before Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery

SWOG Cancer Research Network

Phase 2 Completed
147 enrolled 16 charts
Gastrointestinal

Pancreatic Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡